Versigent (NYSE:VGNT) Stock Has Consensus Price Target of $53.92 According to Brokerages

Shares of Versigent (NYSE:VGNT – Get Free Report) have received a consensus rating of “Moderate Buy” from the fourteen brokerages that are presently covering the company, MarketBeat reports. Three analysts have rated the stock with a hold recommendation and eleven have issued a buy recommendation on the company. The average 1 year price objective among brokers that have updated their coverage on the stock in the last year is $54.00.

A number of research firms recently weighed in on VGNT. Wells Fargo & Company upped their target price on shares of Versigent from $48.00 to $56.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 5th. Zacks Research cut shares of Versigent from a “strong-buy” rating to a “hold” rating in a report on Wednesday, August 5th. The Goldman Sachs Group lowered their target price on shares of Versigent from $59.00 to $58.00 and set a “buy” rating for the company in a research note on Tuesday, October 6th. Royal Bank Of Canada increased their target price on Versigent from $52.00 to $53.00 and gave the company an “outperform” rating in a report on Monday. Finally, Argus raised their price target on Versigent from $50.00 to $54.00 and gave the company a “buy” rating in a research note on Thursday, August 13th.

Read Our Latest Stock Report on Versigent

Versigent Trading Down 1.4%

NYSE:VGNT opened at $43.57 on Friday. The stock has a market capitalization of $3.09 billion and a price-to-earnings ratio of 22.69. The company has a fifty day moving average of $46.40. Versigent has a 12-month low of $26.34 and a 12-month high of $50.88. The company has a debt-to-equity ratio of 7.29, a quick ratio of 1.09 and a current ratio of 1.40.

Versigent (NYSE:VGNT – Get Free Report) last released its earnings results on Tuesday, August 4th. The company reported $1.92 EPS for the quarter, topping the consensus estimate of $1.58 by $0.34. The company had revenue of $2.44 billion for the quarter, compared to analyst estimates of $2.29 billion. Equities analysts forecast that Versigent will post 7.23 EPS for the current year.

Versigent Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 18th. Stockholders of record on Friday, September 4th were given a dividend of $0.13 per share. This represents a $0.52 annualized dividend and a dividend yield of 1.2%. The ex-dividend date of this dividend was Friday, September 4th.

Insider Activity at Versigent

In other news, Director Kevin Clark sold 74,130 shares of the stock in a transaction dated Wednesday, September 9th. The stock was sold at an average price of $45.67, for a total value of $3,385,517.10. Following the transaction, the director owned 124,849 shares in the company, valued at approximately $5,701,853.83. This represents a 37.26% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. In the last quarter, insiders sold 220,000 shares of company stock valued at $10,065,848.

Institutional Investors Weigh In On Versigent

Several institutional investors have recently added to or reduced their stakes in the business. Farther Finance Advisors LLC raised its holdings in shares of Versigent by 53.1% in the third quarter. Farther Finance Advisors LLC now owns 1,052 shares of the company’s stock valued at $47,000 after buying an additional 365 shares during the last quarter. Integrated Wealth Concepts LLC purchased a new position in shares of Versigent during the second quarter worth about $57,000. GAMMA Investing LLC grew its holdings in shares of Versigent by 54.8% during the third quarter. GAMMA Investing LLC now owns 2,249 shares of the company’s stock worth $101,000 after buying an additional 796 shares during the last quarter. Sequoia Financial Advisors LLC purchased a new position in shares of Versigent during the second quarter worth about $220,000. Finally, Kintegral Advisory LLC acquired a new position in Versigent in the 2nd quarter valued at about $224,000.

About Versigent

(Get Free Report)

Versigent PLC is involved in the design, manufacturing and delivery of low and high voltage power electrical architectures. Versigent PLC is based in SCHAFFHAUSEN, Switzerland.

Featured Stories

Analyst Recommendations for Versigent (NYSE:VGNT)

Receive News & Ratings for Versigent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Versigent and related companies with MarketBeat.com's FREE daily email newsletter.